Price (delayed)
$2.15
Market cap
$821.9M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.14
Enterprise value
-$25.35M
Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology
There are no recent dividends present for CRON.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.